Google TrendMICHAEL OLISE (500+) — Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Meeting Patients Where Th" (30 stories)

Top Headline Story

The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Nurses Group – Poster Session (NP001-NP091) | Bone Marrow Transplantation
Lead StoryNatureworld
Jul 10

The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Nurses Group – Poster Session (NP001-NP091) | Bone Marrow Transplantation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9CTHczQkh0VFhXYUtUWFJMQ3ZjNm1SalA2LUdQc09FaHBoYV9oMVZwa1J2RXB6cFl2ZzFwdUd5ZW91ZFJZS0sya044T2Y3OFdBRXE2dGVqb280c1AtNUFz?oc=5" target="_blank">The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Nurses Group – Poster Session (NP001-NP091) | Bone Marrow Transplantation</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
500+19m ago

michael olise

Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay

1000+19m ago

bank of america fine

Bank of America fined $1.2 billion over money-laundering violations

200+19m ago

club brugge

LIVE: Dan toch 1-1! Club laat zich na penalty Tresoldi te makkelijk vangen, Lautaro zorgt voor gelijkmaker

200+19m ago

rb leipzig

Nach 6:0 in der Liga: Demichelis erwartet anderes Kaliber

Search Results for "Meeting Patients Where Th"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
INTerpath-001 Trial of mRNA-Based Individualized Neoantigen Therapy Meets Primary and Key Secondary Endpoints in Patients With High-Risk Resected Melanoma
The ASCO Postgeneral

INTerpath-001 Trial of mRNA-Based Individualized Neoantigen Therapy Meets Primary and Key Secondary Endpoints in Patients With High-Risk Resected Melanoma

<a href="https://news.google.com/rss/articles/CBMingJBVV95cUxQYjUwY3ZSaEtKVks5T2V5OUZpYnFHWjYtUF9kOWhCekVDYnA5dmgzUXB6cDNtUWJMekdzUWpkUmEtWmxnM0llRHRjV2FnWVBDS1JTVWZMV0xKMmNkSG1LMmdvMEg4UlhOOHJoNnpONGtBVlpLWUQ5X3NqaEFQM0VDTEI0dUxYWjF1N1ZyR2FqSTNBMS1ac0JmeDVMRVU0ZnB6UWhwdzVhS3hNNWpGZGJXQVEzUW12alU1R2ZBdkZRVDBrd1pRTjhyT3RzWDdtWmFIWjBtajVfN2U1WFozc0NfUk9pc1RCRFlJQ0hqNlRVejl6aWRVMkl1XzNFeVhZWWp4LURHT1IxMzRDU055bFJCdnN1UkdyY2RzZ3l1ZFR3?oc=5" target="_blank">INTerpath-001 Trial of mRNA-Based Individualized Neoantigen Therapy Meets Primary and Key Secondary Endpoints in Patients With High-Risk Resected Melanoma</a>  <font color="#6f6f6f">The ASCO Post</font>

A pancreatic cancer drug provides new hope: Five things to know about daraxonrasib
Stanford Medicinegeneral

A pancreatic cancer drug provides new hope: Five things to know about daraxonrasib

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNbGxQMlFPSXpWVzcyWFhrUEpqSjdldDFiNDhjTzMtdXk5R0xHbERjQjVyMXBUcGhEUHNzZU95OENhV0NCZ1otZHVmTV9id1UzOW5DVFJ5alZ6dXRETVNuRFY5TWlvdkd6TGN3N2ZPeHE5eFVfVVhuaWQ0ZUhKaUl1Sm1nZjdwMDd6Z1N3ODMwc2lWMmRmR1h5a3ByVWNFQTNFZEE?oc=5" target="_blank">A pancreatic cancer drug provides new hope: Five things to know about daraxonrasib</a>  <font color="#6f6f6f">Stanford Medicine</font>

ASCO 2026: Practice-Shifting Studies to Watch
Oncology News Centralgeneral

ASCO 2026: Practice-Shifting Studies to Watch

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNcHU2RlViZzRNcnRrTWQ3OU1fbnQ2VjZZQTRGY010RmYtOEhEdVhpWXMwaXpFSmxIRExMSVEybHFGQ2I4eDJMdmdzYlpxOWVBeFRsSzItUkN0YjJLWmF0SWljcHhMZTdQRlhTenJtTThiQzFfYUJoSTdIMHFFMDg2MGs4TTV5bVhIQXZINmNybmQ4Y1dndEc2TGFIOGY?oc=5" target="_blank">ASCO 2026: Practice-Shifting Studies to Watch</a>  <font color="#6f6f6f">Oncology News Central</font>

Pope to transplant center: 'Keep the good of the patient as your guiding principle'
Vatican Newsgeneral

Pope to transplant center: 'Keep the good of the patient as your guiding principle'

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOYVEtWVdqb2E5U245eUFGeVo1ckRqWk9nRDBqU09yaHM3X3NUMWZfUTNNMGRuMzFRSGZzVG1YYVBiTXp2Z1phaGQzeTFDbm5uNzZKcjZORjlyS201SDVEVHNuTGF1bVhkbDdvekdSYXdxdnJaRlgwaHV1SHU2bGhsLVdSWmFMY2xBdVpSTEJocERNU25HQmhoajhQTzFnMnpObUZ3Ql8zeUxBbEVzSjBtSA?oc=5" target="_blank">Pope to transplant center: 'Keep the good of the patient as your guiding principle'</a>  <font color="#6f6f6f">Vatican News</font>

The LBAs to Watch for at the 2026 ASCO Meeting
Targeted Oncologygeneral

The LBAs to Watch for at the 2026 ASCO Meeting

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTFBmNXo5dzR4YS1GUXptZ2FwdmcyUWItRU9yMzdkTDRRS0twRmZWN2dfVjRKNGVoaEJvYkZubWZmblBLMl9UNV9wUEJZX2dreGg2d054U3ZRUEp5S01lYWpFRmRkalQ?oc=5" target="_blank">The LBAs to Watch for at the 2026 ASCO Meeting</a>  <font color="#6f6f6f">Targeted Oncology</font>

Rhythm Pharmaceuticals Announces New Data Presentations at
GlobeNewswireworld

Rhythm Pharmaceuticals Announces New Data Presentations at

<a href="https://news.google.com/rss/articles/CBMilwJBVV95cUxNUnBwZEZtLVpIdG5iR2pVY2lpSFZ3bGs2ZHZLbWNRWEpfQ0tvTDB4RFBNQThUT25OVHJhZG5kenBUTDFReHpGQVdzMllES2FGLWtJUUlTc3NaY2Z1Mi1ha04wSDYxU0dSVWhJVzdpR2JWamxENjdqOU9tTVl3c09zcTBYUXI5YXRYcEdXbVhUN1VkY2NoWnhyTnJBWGVrYmxVS3Vuc1VCaTBRb0xxTUVfQTZiOGRJNHJjUUJVMm53VTFwckE3QnhZWVZuRk14UGdkODFBVzlUY1FkSFF6ZUNTYWtvb0owUWNfUDJpMU83Zm16aXV2X081WG1KZTlYR0Vuc0E3enRGajE0amtTSjhiUUcwcGh3Zms?oc=5" target="_blank">Rhythm Pharmaceuticals Announces New Data Presentations at</a>  <font color="#6f6f6f">GlobeNewswire</font>

Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
Business Wireworld

Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting

<a href="https://news.google.com/rss/articles/CBMiygJBVV95cUxOb0xZa2Z6MjhpdENJUHpSNF81WXRZZVliWUZBUFNXS1l0VzFOSzlIQU84S1dHNkxZa01pRnlfb0w1Sl9BSFRFZ29ZZmtkY3NudEY4MzFUTU42T3VVS3lGb2k1VmlRaGdOcVhhSnctSFhtUENEWkZ0dG9xSzRMdVZLcndqRE5JOU96a3k1UnBKZmpDTGlORnRKQVVsNzYyZVRfMFpPc0VvNFg1NF9NSHc0dDBRV1pNUWVFUVRCNW1uVVNTRlV4UXJjR3Ryb2J3VFdtTndaakdWQXBFcjdCS3I3VklPVnlKVUEwM1prdFJlUWVUdGlLdl9hQmFJNEIwR0pvbFVBVnVjem4zMHMtTHRuWDJqaUVfOTQ2LXI4R190aHFxSVlFYVhvQTNGYlc3c3lKdEV3Wk9iamowQ1VMOUREMTY3MHpCOHVUbVE?oc=5" target="_blank">Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting</a>  <font color="#6f6f6f">Business Wire</font>

Meeting patients' needs in the evolving multiple myeloma treatment landscape
Healiogeneral

Meeting patients' needs in the evolving multiple myeloma treatment landscape

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPWkdwOG96THRZN202bENCTDliUXFQLUstM3dlZEM0R2NEX3V3VGUyc2E5anhaY3E1ZExEUjM5WEc0dzYybXdBY091MDU3bjRfMDQxZHg3b1NESi1Od0wzWFJtekN1bC1hVHlNWXRla192ZHpCYmtUanlRdGh3OXZ3LXhnSldyODd4eHN5VFgtQzY5eHVLOWdRNl9TWS1iM1U3MXBmczcwaFJVYkY2bHFxZFE0aHhUc2tsaWVJLTlaNA?oc=5" target="_blank">Meeting patients' needs in the evolving multiple myeloma treatment landscape</a>  <font color="#6f6f6f">Healio</font>

Outside the Four Walls of the Oklahoma City Indian Clinic: A Conversation on Addressing Health Equity
AstraZeneca USscience

Outside the Four Walls of the Oklahoma City Indian Clinic: A Conversation on Addressing Health Equity

<a href="https://news.google.com/rss/articles/CBMilgJBVV95cUxQMHNsQm5QNlZvMEpPdFYxWWNrTnIzNlNlS3Z5UnNTQWszVHFDeXBtLWJNdUVKZDVZNVBRZGI4RXlydTA5cEdzZHFUUlZBTUdIMnJzY2c3NmZ2b0YxVzJyTDJDanVFVE1KRi1GdWhVV280WVhMUFU0eTBCMDE4WVlsd2FVVWxWNDNrNUtic1RHSmhfSlE5U213NjktTFBhRVEzbU1NcEJ3c3dOZW5ONFdKOFpfUEgwRF90VEZsblVIM0JKRjdFXzZYYjR0bTVpZGZ1NFJoeVZ4aEkydm8wbVlRTFNwYThjNkNQSXVYeThuRjVCa19SR2I5d0xrcUtTbG9Mc1BVdjZVWWNYcU9xTnZ1RlhGV21UUQ?oc=5" target="_blank">Outside the Four Walls of the Oklahoma City Indian Clinic: A Conversation on Addressing Health Equity</a>  <font color="#6f6f6f">AstraZeneca US</font>

Do GLP-1 Drugs Like Ozempic Cause or Prevent Vision Loss?
American Academy of Ophthalmologygeneral

Do GLP-1 Drugs Like Ozempic Cause or Prevent Vision Loss?

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQcHRIRzJXREo1NVQ1MXdFbi1QSkRfZ0dNN2NtWU93OUVfWlI1Zy0tb0gtUExHX00zUm01RDNaUTVKRkI2elZ5UUM4VkdFZFVJWXdGVllnV3MzdlVMNGtMMTFncjQyZm9vdVlEVGg4V0xxcEZEVm54RGFybU1Xd1BHenBoMnJoMmxzME1vaWkxVV9rUmJlZEU5TVFuQldYak5iYVE?oc=5" target="_blank">Do GLP-1 Drugs Like Ozempic Cause or Prevent Vision Loss?</a>  <font color="#6f6f6f">American Academy of Ophthalmology</font>

Virtual Urgent Care at Columbia Meets Patients Where They Are
Columbia University Irving Medical Centergeneral

Virtual Urgent Care at Columbia Meets Patients Where They Are

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNWUlRbXR6SDQzWmk3WThMQmxtRzVyZWtxU1FnT1NXZkZ5WUppUTljenRIRVdIYmUxYXJWVTk1U3VsYkZDRlBSd1VpcXNNWGE0eEJXV3RvYlhZOHJBX0Z4a1Y5OG9IaFFFUi1wQ3pTMGFNSEVpdWNQUGs4eWJPcjBSaEY5X1BnODF4ajA0LW5qQWJ3ay1xVGxYZlFB?oc=5" target="_blank">Virtual Urgent Care at Columbia Meets Patients Where They Are</a>  <font color="#6f6f6f">Columbia University Irving Medical Center</font>

Salubris Biotherapeutics Presents Phase 1/2 Dose Escalation and Expansion Cohort Data for JK06, 5T4-Targeted Antibody Drug Conjugate, at the American Association for Cancer Research Annual Meeting
Business Wiregeneral

Salubris Biotherapeutics Presents Phase 1/2 Dose Escalation and Expansion Cohort Data for JK06, 5T4-Targeted Antibody Drug Conjugate, at the American Association for Cancer Research Annual Meeting

<a href="https://news.google.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?oc=5" target="_blank">Salubris Biotherapeutics Presents Phase 1/2 Dose Escalation and Expansion Cohort Data for JK06, 5T4-Targeted Antibody Drug Conjugate, at the American Association for Cancer Research Annual Meeting</a>  <font color="#6f6f6f">Business Wire</font>

Opinion: The FDA needs a patient-first vision—and adcomms with patients at the table
BioSpacegeneral

Opinion: The FDA needs a patient-first vision—and adcomms with patients at the table

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOQUI0NndMeWx1cDU4OEx3bThoV2dWdE5WTzFnT1ZpcThHc19BLTVUWVpPdUdwdEl4UllCRDdVTFVPZ1cwaTVrRHFWNUdDWjFXQXRiYVlCbkYzQl8yYWtQRHVjajV4c3dMZ0ZlR04tNzF0UkZjSTFRdklDaGFZWHhiV0tvZUlVYldhdXBOTXliMm1zRmNPMEphVlhuc0g3UTNpLThQSWdyRzRob0c4ck1jNW9R?oc=5" target="_blank">Opinion: The FDA needs a patient-first vision—and adcomms with patients at the table</a>  <font color="#6f6f6f">BioSpace</font>

Multidisciplinary Team Meetings: Barriers to Implementation in Cancer Care
CancerNetworkgeneral

Multidisciplinary Team Meetings: Barriers to Implementation in Cancer Care

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNWjdaUktYVC1TVEtoa1ZHTk5mYTQ1STlGbnJuSFBIb1RIclQwSl9HTFZ3akFvT1ZqZFVXQk5XeVNOUGNaTTZLY05Gcm9RSGd6RU42c1FvYWRpQWU2YzQzcTNqdHFFdXpRTVBpNXJrVWhnLUxwd2dtRkp1ZlRjUmtpS1ZmQy12c1VmcXBURWRzSzBud0J4WWxnSktIaDg2N1hiaERYZFRvaC02Tm5w?oc=5" target="_blank">Multidisciplinary Team Meetings: Barriers to Implementation in Cancer Care</a>  <font color="#6f6f6f">CancerNetwork</font>

Little Rock Selected for Largest American Kidney Patient Meeting
PR Newswiregeneral

Little Rock Selected for Largest American Kidney Patient Meeting

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQY3dzQXpZM0RrbFJXc3hQR3dkR0ozaGJKUnRLclJCbGdCZ0FDeWhBbEtDMzVTSFNaQU0zSGhpVFA5d0xubnVFNEtOalhQRWkyUUJKZmdYVmRiMlY2MjE4Si14R0pXT0NQVERuSU0zZEJseXZXcnV3VmZuM3cyb2VMUDZDQ1UtZ1N1UF94c2JKT0xhcDhmRmhqWHJYZDlHNWxWdVNtZEN5SVk1NzBMQ1kyQS1LNTBkZ3gtb0lIYg?oc=5" target="_blank">Little Rock Selected for Largest American Kidney Patient Meeting</a>  <font color="#6f6f6f">PR Newswire</font>

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates
Intellia Therapeuticsworld

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQMnFmUldtWXRfdEFBYUpSWW8wdE5SRjZzQmpsVmRpNlBZc2FRQU1wQWttQXJoLVFENm1ENUR3eF9zMkRGQy1VdmV1cXhleDRJTk13OXdHM1dUeXQydnptSUswdWlyY0VTQU5FbXJCWTFlZzRTWHRxaV85X2s0RHhYUFRsVGJVQWIxSnVQalVXZF9YNjBBcnZfSXk4b3c2eGxVV1gyNXhveTRaQ0R6eUstT3NQZ3BXcWZhYW5tVl93?oc=5" target="_blank">Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates</a>  <font color="#6f6f6f">Intellia Therapeutics</font>

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Patient Advocacy – Poster Session (P758-P762) | Bone Marrow Transplantation
Natureworld

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Patient Advocacy – Poster Session (P758-P762) | Bone Marrow Transplantation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBaSlQybjB4M3R0R3VmT21KSlNtdjZReXBYY1FaQ1JoVFJtYkV2OUhlTlhFMDRtTUhIUkxJT1hZT0NmTUV3ZmZnZ045V0lVV1pSV1VjTDZERXFnRldDRzdn?oc=5" target="_blank">The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Patient Advocacy – Poster Session (P758-P762) | Bone Marrow Transplantation</a>  <font color="#6f6f6f">Nature</font>

Stealth BioTherapeutics Announces Positive End-of-Phase 2 Meeting with FDA on the Development of Elamipretide in Patients with Dry Age-related Macular Degeneration
PR Newswireworld

Stealth BioTherapeutics Announces Positive End-of-Phase 2 Meeting with FDA on the Development of Elamipretide in Patients with Dry Age-related Macular Degeneration

<a href="https://news.google.com/rss/articles/CBMiwAJBVV95cUxOZ2JVYUlmVndvS2tDSmducmYxaE0zRDZXcFNDNk9GTkpvS05GQzVVckNteXhlLTdsdXhHVXJzRFptdTRJbXl0T0pXbEJYbW12X0xHYm96X2d6OGpwcHItNlhuaTFoY190QVFIUWV5S2xkbUxNNFMzSm8xWVlja3EwVlF5N1ZSMXJPeXhMdjVVdVBiU1laRXZ5Vjg4OGJwNF9aT2pyeUpDaGI4cTFBVXJVVW9BSHFZOVlkM2w0ZG9JUzByc1BTSXlfNEItQ1JEQ0R2WnVWOVQteU5NQnJFeWktMjN1Y3R6akZMa0tjTVVfeWJmTUktVE9zbUhsbS1ZU3RZRElsZVVmRkM2aVo4NFB5QkR3ZnRwUjFMa3ZJOEVWNGtzSnJ2ZmVpMWMxeWotVnRLb04wa2ZrNXdEVXczVmdhcA?oc=5" target="_blank">Stealth BioTherapeutics Announces Positive End-of-Phase 2 Meeting with FDA on the Development of Elamipretide in Patients with Dry Age-related Macular Degeneration</a>  <font color="#6f6f6f">PR Newswire</font>

Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress
Intellia Therapeuticsworld

Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPSlViRnNGOUQxU01NOTFhdEV3Q3lDR0Q4OE5SMnJpMzlFTGVCTTBUMFBVM2V4RlNaV2wzUkZNRnRqNDZEV2V2bVJFUzR2dnlLeVFSMjY5Y3Z0RGo4bDJiUUtFTU1PZ3ZtYzhwd3o1WW9QX29ab0NXNHMtYmFvcGZxSDZSRzdUOFl2WEdKd3hGWlktMU9udzlrMHduUDRSSklNdkNTYi1KbnNlNGFDT25zanByY3hHUUZzQ1Jlc2hkOA?oc=5" target="_blank">Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress</a>  <font color="#6f6f6f">Intellia Therapeutics</font>

2021 ASCO Annual Meeting Preview: Connect With One of the Largest, Most Diverse Audiences in Oncology
ASCO Connectiongeneral

2021 ASCO Annual Meeting Preview: Connect With One of the Largest, Most Diverse Audiences in Oncology

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYmNjLVlwNFdsWkZZXzRMeHVRdzBWUU9mVWFXcG8xVm91LUtHdmtqU09NTlpRcEQ1SVNNVGJzU0hCazBjdXVOYnp3MVREb0JYcUNEN2FjSzgzbHU0UFJVNXVhV0tXVTVjX0ViSFdvR19lU1NjN185a3FOMjIySFZnZ3gxTFBBR05FYmFJcGhPUzVwWDdsQkNxb2ptY2xhS2hPZkloaDhfa1pIQQ?oc=5" target="_blank">2021 ASCO Annual Meeting Preview: Connect With One of the Largest, Most Diverse Audiences in Oncology</a>  <font color="#6f6f6f">ASCO Connection</font>

Latest Evolution of LASIK Technology Shows Superior Results in New Study
American Academy of Ophthalmologytech

Latest Evolution of LASIK Technology Shows Superior Results in New Study

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOa0x1RU1fdTVjSjFtd3pOLXV5eTh0OEF4MW45WHhOVHBTNXI4MC0weWVGR0NQOFdQNXpaelo3VDFFYWJlVnEzNEZiS3ctRFYtbzBiRUJuaU4yTVVzZGpCMExRUHJOYk5CY3p5NzNaNHdzNWF5cFNvODBsUFRZcjZQSmhiU2tuQ0NvZGQzQlJkZ1p5Q3YxZWllLUE3LUQ1UXpZWGc?oc=5" target="_blank">Latest Evolution of LASIK Technology Shows Superior Results in New Study</a>  <font color="#6f6f6f">American Academy of Ophthalmology</font>

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27th Annual Neuromuscular Study Group Scientific Meeting
Sarepta Therapeuticsgeneral

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27th Annual Neuromuscular Study Group Scientific Meeting

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQVVRhaVlMZzdTaG9wY0xjV3ZsdFltdE8yYjN2MWhtTmtTNDdnVm1vM1RNblR4OExqTWtWa21IeDRXb2liaHdKc2xqMDA0TV94M2h2cDRVQ3hYWG15NmVRdlAyMWpLUGFmQkIzM3RKdzZwNnMyNTdBU1ZJSmRUZmNaSG9qYU4zQ2FoV1ptSjNKMXUwdUNsX29CRFR3Q3pWVDI3Ylh2REtRVjJsSWl4VkxsWFA3U1dOdHNhY0VMSmpPVFMwYUprUnI3U2RB?oc=5" target="_blank">Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27th Annual Neuromuscular Study Group Scientific Meeting</a>  <font color="#6f6f6f">Sarepta Therapeutics</font>

Extension of Lecanemab Trial Shows Continued Benefit
Neurology Todaygeneral

Extension of Lecanemab Trial Shows Continued Benefit

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE9NNnEzRk9Ldk9YdEQtU25XV3BBTGpWTHlRMjdTX2YxbEN6bmFtZGJHZm5vLXB6NkN1VE5XX2IzNVdfNFkxZHhoMmN2eUd2MEdmbFNQZVMtcGZteGxJR2VGZHZ3WF9Ma25HSWFSUWZDcm8?oc=5" target="_blank">Extension of Lecanemab Trial Shows Continued Benefit</a>  <font color="#6f6f6f">Neurology Today</font>

Neurology Practices Create Systems for Meeting Demand for Anti-Amyloid Therapies
Neurology Todaygeneral

Neurology Practices Create Systems for Meeting Demand for Anti-Amyloid Therapies

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE1iRE1xV1ZLYUFTOE5Sa3FYMzIwTm9TWEoxOUlzWGV2MjFIcWZMRnI0dDJyQ0xudzJuVnZwaE4zSi1rSFVLT2E0ZTJEeUhWN1Z2R0JpaXF1WTJ1YTZzRFQzb3AzOVBPcElFZUdrTXRsbE41Z0V5NkxN?oc=5" target="_blank">Neurology Practices Create Systems for Meeting Demand for Anti-Amyloid Therapies</a>  <font color="#6f6f6f">Neurology Today</font>

From the 2021 ASCO Annual Meeting
Naturegeneral

From the 2021 ASCO Annual Meeting

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBGT0tWd0dLR3pUM1pIWlNRM3BZQ0dVSW4wZEFBZWI1QmVvMjdYMWdwYnRYa1pfeVV1Mzh0QjJ6MzBZYXZUTFktb2JxaFZpbDBXZVZFNDQyMTVacnFIY19n?oc=5" target="_blank">From the 2021 ASCO Annual Meeting</a>  <font color="#6f6f6f">Nature</font>

Ukraine‘s First Lady meets Pope and visits patients at Vatican Children's Hospital
Vatican Newstech

Ukraine‘s First Lady meets Pope and visits patients at Vatican Children's Hospital

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOTjVRek5lQnRVa3Jfd3BhRXMzZTFzbTRfa3J5cHdBdTZaTTdEUFJWdHN5RVNHdmR5YVZiUjhsbWlOSUpzUWREd01mdl9ZcjNNQS1kQWRQT1FKWW1mNFFySkZCQUVKLUF3OU55ODJzdTZCZzBuc3FEa2RXY2tZZGM0RWxEdFdqMmg4Tkk0c2dKSkRPc0VXUEt5aE9JMktsYXN1aVJWYjhYTjVXNUVpRmpNaGVjTjFHckVGT1p5bUJSd09HUQ?oc=5" target="_blank">Ukraine‘s First Lady meets Pope and visits patients at Vatican Children's Hospital</a>  <font color="#6f6f6f">Vatican News</font>

2026 ASCO Annual Meeting: Join the Conversations That Will Improve Tomorrow’s Outcomes
ASCO Connectiongeneral

2026 ASCO Annual Meeting: Join the Conversations That Will Improve Tomorrow’s Outcomes

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOQ2x0c3FtN0pNbnJ1WjMzUjVSU0swWnkwRlZHeHhLR0pWYS1LMlJLRVhlMXVVd3dGcGxEMEhpOGlNQTlTbDA2WlVlNDVWV3JKYnpYcjdacDEyeGRDLUUtMzhWWmJqNXV4a1VZNk15X2Y4OWNBUWRBZEhEMTNlSzhPenVyVW4yV3dSVmpWX1JRaEFnd01DYVRORFNkWXptQ0ZydjNsbw?oc=5" target="_blank">2026 ASCO Annual Meeting: Join the Conversations That Will Improve Tomorrow’s Outcomes</a>  <font color="#6f6f6f">ASCO Connection</font>

39th Annual Seminar by the Sea Northeast Regional Hybrid Conference
The University of Rhode Islandgeneral

39th Annual Seminar by the Sea Northeast Regional Hybrid Conference

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQZmstbVFlOEVOUWhURjVqdmplb3ZtQ0xJN291SXFXUzl3YWE5YWx2ZFQ2ZTA3ZERmNm1DRWM0RG9OOERBQm1YT1h3Q0hfWjVSMGNSelNreDJ5REdpbmVrdGw3dk03czhYbGsydW9FY2xiRm5fRHFxeWZiTXEta1BVdk1XV2Z1dGtVemx4X1RWNkNVN0JJMFVlTlk3RzR6RTg?oc=5" target="_blank">39th Annual Seminar by the Sea Northeast Regional Hybrid Conference</a>  <font color="#6f6f6f">The University of Rhode Island</font>

Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
PR Newswireworld

Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference

<a href="https://news.google.com/rss/articles/CBMitgJBVV95cUxNbHA5TzZ4bnVPeGd6a0pZbmRRUF9UaVpVX3E3c0RrUHp2M290TndQWDJLMm9VMzZfcWFNREhtaWN4dFd0Uzl2cTR0bjVaRER3dUs0eG1SVExEQjd6eFF6X1FUdzY5VjR6Qmx6dGlVSXhtVzh1NWJxRkZxcmsxZUwwMWhjVFE0bzR1SFVCMEQxMmV2LTA4VGdqalhDNTNGVFZGS1RSdnRCNjB3Tnhnbk84QXZab0RjblBHRmN5b0hya3lIbEc1anVRekVyZU4zT2NMQlNJX19zVU1pX29ycGtWMkpDbWRPYVowUjR1cG43emZPY3lMZ2N6Z2VnT1JjUzgxRC1QaEM3cUhJZUQ0MTcxOHY4dnBEZlJqVXVUVzF0azI4NEhvcnRGb0g2LVh4OEhmNU9uYm9R?oc=5" target="_blank">Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference</a>  <font color="#6f6f6f">PR Newswire</font>

"Meeting Patients Where Th" — Live Google News Trends & Headlines